Progyny (PGNY) Peer Comparison
$26.85
$-0.28
(-1.03%)
As on 21-Sep-2026 14:36EDT
Market cap
$2,082 Mln
Revenue (TTM)
$1,311 Mln
P/E Ratio
29.2
P/B Ratio
4.6
Div. Yield
0 %
Edit
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2,082 | 11,746 | 1,732 | 2,369 | 336,787 |
Revenue ($ Mln) |
1,311 | 19,427 | 4,577 | 2,477 | 450,129 |
Net Profit ($ Mln) |
78.63 | 937.78 | 40.70 | -18.36 | 14,122.00 |
Net Margin (%) |
6.00 | 4.83 | 0.89 | -0.74 | 3.14 |
RoE (%) |
16.22 | 5.13 | 18.32 | -5.36 | 13.85 |
Price to Earnings |
29.17 | 11.99 | 43.95 | -- | 24.10 |
Price-To-Book |
4.57 | 0.84 | 6.80 | 6.30 | 3.42 |
Income Statement ($ Mln)
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,310.76 | 19,427.15 | 4,577.33 | 2,476.71 | 450,129.00 |
|
Cost of Revenue
|
988.68 | 14,307.08 | 4,002.91 | 2,016.79 | 348,915.00 |
|
Gross Profit
|
304.48 | 5,028.93 | 488.56 | 355.88 | 82,917.00 |
|
Operating Expenses
|
209.96 | 3,227.96 | 519.42 | 478.29 | 79,538.00 |
|
Operating Profit (EBIT)
|
112.13 | 1,892.11 | 55.00 | -18.36 | 21,676.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
119.84 | 1,501.55 | 38.77 | -18.36 | 17,440.00 |
|
Provision for Tax
|
41.21 | 314.25 | -1.93 | 0.00 | 2,528.00 |
|
Profit after Tax (Net Income)
|
78.63 | 937.78 | 40.70 | -18.36 | 14,122.00 |
|
Minority Interest
|
0.00 | -249.52 | 0.00 | 0.00 | -790.00 |
|
Consolidated Profit
|
0.00 | 601.88 | 0.00 | 0.00 | 2,358.00 |
Liabilities ($ Mln)
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
453.26 | 12,556.71 | 265.13 | 376.26 | 98,447.00 |
|
Minority Interest
|
0.00 | -249.52 | 0.00 | 0.00 | -790.00 |
|
Non-Current Liabilities
|
22.50 | 10,584.44 | 330.50 | 20.74 | 91,958.00 |
|
Current Liabilities
|
240.08 | 7,177.55 | 683.41 | 323.33 | 111,820.00 |
|
Total Liabilities
|
742.44 | 31,002.00 | 1,065.79 | 541.01 | 309,581.00 |
Assets ($ Mln)
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
202.82 | 23,603.95 | 118.59 | 234.88 | 222,867.00 |
|
Current Assets
|
513.02 | 7,689.29 | 1,160.45 | 485.45 | 86,860.00 |
|
Total Assets
|
742.44 | 31,002.00 | 1,065.79 | 541.01 | 309,581.00 |
|
Total Debt*
|
26.97 | 10,963.35 | 330.50 | 0.00 | 73,328.00 |
|
Net Current Assets
|
272.93 | 511.74 | 477.04 | 162.12 | -24,960.00 |
Cashflow ($ Mln)
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
210.19 | 2,575.19 | 139.93 | -66.93 | 19,697.00 |
|
Cash Flow from Investing Activities
|
-159.01 | -666.18 | -14.97 | 4.08 | -8,685.00 |
|
Cash from Financing Activities
|
-99.36 | -1,375.66 | 18.04 | -53.38 | -11,644.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
11.88 | 3.86 | -0.15 | -26.33 | 7.05 |
|
ROE (%)
|
16.22 | 5.13 | 18.32 | -5.36 | 13.85 |
|
ROA (%)
|
8.12 | 2.49 | 2.33 | -2.02 | 3.36 |
|
EBIT Margin (%)
|
9.14 | 9.62 | 1.20 | -0.74 | 4.77 |
|
Net Margin (%)
|
6.00 | 4.83 | 0.89 | -0.74 | 3.14 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
5.54 | -0.47 | 37.21 | 54.03 | 6.46 |
|
EBIT Growth (%)
|
34.30 | 20.38 | 299.13 | 56.95 | -30.03 |
|
Net Profit Growth (%)
|
48.02 | 42.86 | 179.88 | 57.40 | -33.69 |
|
EPS Growth (%)
|
58.47 | 88.68 | 168.54 | 53.73 | -32.69 |
|
Book Value Growth (%)
|
-3.96 | 2.98 | 83.26 | 1.99 | 4.39 |
Valuation Ratios
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
39.26 | 13.92 | -5,482.29 | -14.21 | 24.92 |
|
Price / Book Value
|
4.45 | 0.95 | 22.14 | 3.94 | 3.19 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
20.07 | 6.65 | 81.52 | -13.36 | 15.21 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.46 | 1.22 | 0.00 | 0.71 |
|
Short term debt to equity ratio
|
0.01 | 0.19 | 0.00 | 0.00 | 0.04 |
|
Current Ratio
|
2.14 | 1.07 | 1.70 | 1.50 | 0.78 |
|
Quick Ratio
|
2.14 | 0.75 | 1.70 | 1.50 | 0.78 |
|
Interest Coverage
|
-- | 4.92 | 3.39 | -- | 5.48 |
Operating Efficiency Ratios
| Progyny (PGNY) | Fresenius Medical Care AG - ADR | Alignment Healthcare LLC (ALHC) | Clover Health Investments Corp. Class A (CLOV) | UnitedHealth Group Incorporated (DE) (UNH) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.64 | 17.84 | 6.49 | 8.19 | 10.28 |
|
Asset Turnover
|
1.35 | 0.52 | 2.62 | 2.72 | 1.07 |
|
Receivable days
|
64.57 | 60.95 | 18.83 | 23.87 | 41.28 |
|
Inventory Days
|
-- | 52.65 | -- | -- | -- |
|
Payable days
|
40.67 | 21.55 | 34.74 | 8.24 | 73.09 |
|
Cash Conversion Cycle
|
-- | 92.06 | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
